Last updated: July 17, 2026

Application No. 18/689,708

SUBSTITUTED 2,3-DIHYDRO[1,3]THIAZOLO[4,5-B]PYRIDINES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES

Non-Final OA

Filed

Mar 06, 2024

Priority

Sep 07, 2021 — EU 21195216.3 +1 more

Examiner

ROZOF, TIMOTHY R

Art Unit

1625

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Bayer Aktiengesellschaft

OA Round

1 (Non-Final)

Interview Optional

— +24.0% interview lift. Interview already conducted in this application's prosecution history. This examiner has a 73% grant rate with +24.0% interview lift. Since an interview has already been tried, recommend written response with narrowed claims based on precedent claim evolution patterns.

Based on 960 resolved cases, 2023–2026

Examiner Intelligence

ROZOF, TIMOTHY R View full profile →

Grants 73% — above average

Career Allowance Rate

697 granted / 960 resolved

+12.6% vs TC avg

Strong +24% interview lift

Without

With

+24.0%

Interview Lift

resolved cases with interview

Fast prosecutor

2y 0m

Avg Prosecution

49 currently pending

Career history

992

Total Applications

across all art units

Statute-Specific Performance

§101

1.0%

-39.0% vs TC avg

§103

23.8%

-16.2% vs TC avg

§102

27.9%

-12.1% vs TC avg

§112

21.2%

-18.8% vs TC avg

Black line = Tech Center average estimate • Based on career data from 960 resolved cases

Prosecution Timeline

Mar 06, 2024

Application Filed

Mar 24, 2026

Examiner Interview (Telephonic)

Mar 26, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/915,179

Patent 12679843

PYRROLOPYRIMIDINE AMINES AS COMPLEMENT INHIBITORS

2y 10m to grant Granted Jul 14, 2026

18/263,546

Patent 12661359

THERAPEUTIC COMBINATIONS OF ROSUVASTATIN AND RESMETIROM FOR THE TREATMENT OF LIVER DISORDERS OR LIPID DISORDERS

2y 10m to grant Granted Jun 23, 2026

18/270,351

Patent 12662462

SALTS OF PYRIDINYLMETHYLENEPIPERIDINE DERIVATIVES AND USES THEREOF

2y 12m to grant Granted Jun 23, 2026

18/257,540

Patent 12649744

N-(PYRIDIN-2-YL)-6,7,8,9-TETRAHYDRO-5H-5,8-EPIMINOCYCLOHEPTA[C]PYRIDINE-10-CARBOXAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS GPR65 MODULATORS FOR THE TREATMENT OF CANCER

2y 12m to grant Granted Jun 09, 2026

18/282,872

Patent 12649748

WEE1 INHIBITOR AND USE THEREOF

2y 8m to grant Granted Jun 09, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

73%

Grant Probability

97%

With Interview (+24.0%)

2y 0m (~0m remaining)

Median Time to Grant

Low

PTA Risk

Based on 960 resolved cases by this examiner. Grant probability derived from career allowance rate.